Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Plus Therapeutics (PSTV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Plus Therapeutics (PSTV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Plus Therapeutics (PSTV) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

Urban Outfitters (URBN) Earnings Expected to Grow: Should You Buy?
Urban Outfitters (URBN) Earnings Expected to Grow: Should You Buy?

The market expects Urban Outfitters (URBN) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus

Analysts Estimate Target (TGT) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Target (TGT) to Report a Decline in Earnings: What to Look Out for

Wall Street expects a year-over-year decline in earnings on lower revenues when Target (TGT) reports results for the quarter ended April 2025. While this widely-known consensus outlook is important

Analysts Estimate Lowe's (LOW) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Lowe's (LOW) to Report a Decline in Earnings: What to Look Out for

Lowe's (LOW) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook gives a good

Domo (DOMO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Domo (DOMO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Wall Street expects a year-over-year increase in earnings on lower revenues when Domo (DOMO) reports results for the quarter ended April 2025. While this widely-known consensus outlook is important

Analysts Estimate Zoom Communications (ZM) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Zoom Communications (ZM) to Report a Decline in Earnings: What to Look Out for

Zoom Communications (ZM) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook

Expeditors Rewards Shareholders With 5.5% Dividend Hike
Expeditors Rewards Shareholders With 5.5% Dividend Hike

In a shareholder-friendly move, Expeditors International of Washington, Inc. EXPD has announced a hike in its dividend payout. Expeditors’ board of directors has approved a dividend hike of 5.5%

Wall Street Analysts See a 40.5% Upside in Sangoma Technologies Corporation (SANG): Can the Stock Really Move This High?
Wall Street Analysts See a 40.5% Upside in Sangoma Technologies Corporation (SANG): Can the Stock Really Move This High?

Sangoma Technologies Corporation (SANG) closed the last trading session at $5.95, gaining 29.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Wall Street Analysts Think Zymeworks (ZYME) Could Surge 83.89%: Read This Before Placing a Bet
Wall Street Analysts Think Zymeworks (ZYME) Could Surge 83.89%: Read This Before Placing a Bet

Zymeworks Inc. (ZYME) closed the last trading session at $11.61, gaining 6.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts See a 161.51% Upside in uniQure (QURE): Can the Stock Really Move This High?
Wall Street Analysts See a 161.51% Upside in uniQure (QURE): Can the Stock Really Move This High?

uniQure (QURE) closed the last trading session at $12.81, gaining 32.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Wall Street Analysts Think Crexendo (CXDO) Could Surge 42.86%: Read This Before Placing a Bet
Wall Street Analysts Think Crexendo (CXDO) Could Surge 42.86%: Read This Before Placing a Bet

Crexendo (CXDO) closed the last trading session at $5.81, gaining 24.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Does Edgewise Therapeutics (EWTX) Have the Potential to Rally 174.68% as Wall Street Analysts Expect?
Does Edgewise Therapeutics (EWTX) Have the Potential to Rally 174.68% as Wall Street Analysts Expect?

Shares of Edgewise Therapeutics, Inc. (EWTX) have gained 14.4% over the past four weeks to close the last trading session at $14.89, but there could still be a solid upside left in the stock if

Wall Street Analysts See a 195.05% Upside in Trevi Therapeutics (TRVI): Can the Stock Really Move This High?
Wall Street Analysts See a 195.05% Upside in Trevi Therapeutics (TRVI): Can the Stock Really Move This High?

Shares of Trevi Therapeutics, Inc. (TRVI) have gained 4.1% over the past four weeks to close the last trading session at $6.46, but there could still be a solid upside left in the stock if

Wall Street Analysts Believe Xperi (XPER) Could Rally 118.82%: Here's is How to Trade
Wall Street Analysts Believe Xperi (XPER) Could Rally 118.82%: Here's is How to Trade

Xperi (XPER) closed the last trading session at $8.34, gaining 27.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Wall Street Analysts Believe Pagaya Technologies Ltd. (PGY) Could Rally 51.67%: Here's is How to Trade
Wall Street Analysts Believe Pagaya Technologies Ltd. (PGY) Could Rally 51.67%: Here's is How to Trade

Pagaya Technologies Ltd. (PGY) closed the last trading session at $14.96, gaining 49.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Wall Street Analysts Believe Janus International Group (JBI) Could Rally 27.06%: Here's is How to Trade
Wall Street Analysts Believe Janus International Group (JBI) Could Rally 27.06%: Here's is How to Trade

Janus International Group, Inc. (JBI) closed the last trading session at $8.50, gaining 35.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Should You Buy Amphenol (APH) After Golden Cross?
Should You Buy Amphenol (APH) After Golden Cross?

Amphenol Corporation (APH) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, APH's 50-day simple moving average broke out above its

After Golden Cross, Allient (ALNT)'s Technical Outlook is Bright
After Golden Cross, Allient (ALNT)'s Technical Outlook is Bright

After reaching an important support level, Allient Inc. (ALNT) could be a good stock pick from a technical perspective. ALNT recently experienced a "golden cross" event, which saw its 50-day simple

Babcock International Group (BCKIY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Babcock International Group (BCKIY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Shares of Babcock International Group PLC (BCKIY) have been struggling lately and have lost 9% over the past week. However, a hammer chart pattern was formed in its last trading session, which could

Air Lease (AL) Now Trades Above Golden Cross: Time to Buy?
Air Lease (AL) Now Trades Above Golden Cross: Time to Buy?

Air Lease Corporation (AL) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, AL's 50-day simple moving average crossed above

Here's Why Rigel (RIGL) Is a Great 'Buy the Bottom' Stock NowPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Here's Why Rigel (RIGL) Is a Great 'Buy the Bottom' Stock Now

The price trend for Rigel Pharmaceuticals (RIGL) has been bearish lately and the stock has lost 6.5% over the past two weeks. However, the formation of a hammer chart pattern in its last trading

Why The Charles Schwab Corporation (SCHW) is a Top Momentum Stock for the Long-Term
Why The Charles Schwab Corporation (SCHW) is a Top Momentum Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Here's Why MercadoLibre (MELI) is a Strong Momentum Stock
Here's Why MercadoLibre (MELI) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Why Carvana (CVNA) is a Top Momentum Stock for the Long-Term
Why Carvana (CVNA) is a Top Momentum Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates